Loader

Pathways

PathWhiz ID Pathway Meta Data

PW120522

Pw120522 View Pathway
signaling

OX40 Signaling Pathway

Homo sapiens
OX40 is a type 1 transmembrane glycoprotein, reported nearly 30 years ago as a cell surface antigen expressed on activated T cells. Since its discovery, it has been validated as a bone fide costimulatory molecule for T cells and member of the TNF receptor family. Tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), also known as CD134 and OX40 receptor, is a fellow of the TNFR-superfamily of receptors. It is a protein which in humans is encoded by the TNFRSF4 gene which contains 9 exons. It also has been demonstrated to have a key role in the survival and homeostasis of effector and memory T cells in transplantation and autoimmunity. OX40 is not constitutively expressed on resting naive T cells, unlike CD28. As a secondary co-stimulatory immune checkpoint molecule, it expresses after 24 to 72 hours following activation; its ligand, OX40L, is also not expressed on resting antigen presenting cells and resting naive T cells, but is following their activation. Expression of OX40 is dependent on full activation of the T cell and the expression of CD28; without CD28, expression of OX40 is delayed and of fourfold lower levels.

PW127494

Pw127494 View Pathway
drug action

Oxacillin Action Pathway

Streptococcus pneumoniae (strain ATCC BAA-255 / R6)
Oxacillin is a penicillin antibiotic used to treat a number of susceptible bacterial infections. Oxacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Oxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Oxacillin interferes with an autolysin inhibitor.

PW144825

Pw144825 View Pathway
drug action

Oxacillin Drug Metabolism Action Pathway

Homo sapiens

PW132200

Pw132200 View Pathway
metabolic

Oxaliplatin Drug Metabolism

Homo sapiens
Oxaliplatin is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Oxaliplatin passes through the liver and is then excreted from the body mainly through the kidney.

PW144644

Pw144644 View Pathway
drug action

Oxaliplatin Drug Metabolism Action Pathway

Homo sapiens

PW145186

Pw145186 View Pathway
drug action

Oxamniquine Drug Metabolism Action Pathway

Homo sapiens

PW176280

Pw176280 View Pathway
metabolic

Oxamniquine Predicted Metabolism Pathway

Homo sapiens
Metabolites of Oxamniquine are predicted with biotransformer.

PW132516

Pw132516 View Pathway
metabolic

Oxandrolone Drug Metabolism

Homo sapiens
Oxandrolone is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Oxandrolone passes through the liver and is then excreted from the body mainly through the kidney.

PW144735

Pw144735 View Pathway
drug action

Oxandrolone Drug Metabolism Action Pathway

Homo sapiens

PW000262

Pw000262 View Pathway
drug action

Oxaprozin Action Pathway

Homo sapiens
Oxaprozin (also named Daypro, Dayrun) is a nonsteroidal anti-inflammatory drug (NSAID). It can be used to relieve pain (analgesic) and reduce fever (antipyretic). Oxaprozin is also a type of ophthalmic anti-inflammatory medicines which may be used to help prevent eye constrict for pupil during surgery. Oxaprozin can block prostaglandin synthesis by the action of inhibition of prostaglandin G/H synthase 1 and 2. Prostaglandin G/H synthase 1 and 2 catalyze the arachidonic acid to prostaglandin G2, and also catalyze prostaglandin G2 to prostaglandin H2 in the metabolism pathway. Since prostaglandin is the messenger molecules in the process of inflammation; hence, inhibition of prostaglandin synthesis can reduce the pain and inflammation.